| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Mario Negri Institute for Pharmacological Research, Via Eritrea, 62, 20157 Milan, Italy [C. L., E. N., B. D.]; Institute of Social and Preventive Medicine, University of Lausanne, 1005 Lausanne, Switzerland [C. L., F. L.]; Institute of Medical Statistics, University of Milan, 20133 Milan, Italy [M. F., A. D.]; and Oncological Referral Centre, 33081 Aviano, Pordenone, Italy [S. F.]
The relationship between coffee drinking and the risk of digestive tract neoplasms was analyzed in a case-control study of 50 cases of cancer of the mouth or pharynx, 209 of the esophagus, 397 of the stomach, 455 of the colon, 295 of the rectum, 151 of the liver, 214 of the pancreas, and 1944 control subjects admitted for acute, non-digestive tract disorders. There was no significant or consistent association between coffee and cancers of the mouth or pharynx, esophagus, stomach, liver, or pancreas. In particular, for pancreatic cancer, the multivariate relative risks for the intermediate and upper tertiles were 1.05 and 1.01, respectively. There were significant inverse trends in risk with measures of coffee consumption for colon and rectal cancers, the multivariate relative risks according to tertiles of coffee consumption being 0.86 and 0.64 for colon and 0.97 and 0.66 for rectum. This apparent protection is in agreement with some (but not all) previous epidemiological evidence and finds a possible biological interpretation in terms of interference on bile secretion, causing reduced bile acid and neutral sterol concentrations in the bowel. In conclusion, the results of this study, the major interest of which lies in the opportunity of drawing up an overall pattern of risk for various digestive neoplasms, offer further reassurance as regards the effects of coffee on digestive tract carcinogenesis.
1 This work was conducted within the framework of the CNR (Italian National Research Council) Applied Project "Oncology" (Contract 87.01544.44). The contributions of the Italian League Against Tumours, Milan, Italy, and of the Italian Association for Cancer Research are gratefully acknowledged.
2 To whom requests for reprints should be addressed.
Received 7/ 1/88. Revised 10/13/88. Accepted 10/20/88.
This article has been cited by other articles:
![]() |
T. Naganuma, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, Y. Nishino, A. Fukao, and I. Tsuji Coffee Consumption and the Risk of Oral, Pharyngeal, and Esophageal Cancers in Japan: The Miyagi Cohort Study Am. J. Epidemiol., December 15, 2008; 168(12): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, I. Yoshimi, T. Sobue, S. Tsugane, and For the JPHC Study Group Influence of Coffee Drinking on Subsequent Risk of Hepatocellular Carcinoma: A Prospective Study in Japan J Natl Cancer Inst, February 16, 2005; 97(4): 293 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Olthof, P. C. H. Hollman, and M. B. Katan Chlorogenic Acid and Caffeic Acid Are Absorbed in Humans J. Nutr., January 1, 2001; 131(1): 66 - 71. [Abstract] [Full Text] |
||||
![]() |
H. E KUPER, L. A MUCCI, and D. TRICHOPOULOS Coffee, pancreatic cancer and the question of causation J Epidemiol Community Health, September 1, 2000; 54(9): 650 - 651. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |